Stocktoria
Aveanna Healthcare Holdings, Inc. AVAH
Aveanna Healthcare Holdings, Inc. (AVAH) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2026 revenue was $2.4B at a 9.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.07 — grey zone (between the usual thresholds). A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.067 |
| Retained earnings / assets | -0.575 |
| EBIT / assets | 0.127 |
| Equity / liabilities | 0.107 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AVAH | Aveanna Healthcare Holdings, Inc. | 6/9 | -0.46 | 8.4 | +20.2% |
| CHE | CHEMED CORP | 5/9 | 9.65 | 23.2 | +4.1% |
| AHCO | AdaptHealth Corp. | 5/9 | 0.26 | — | -0.5% |
| ADUS | Addus HomeCare Corp | 7/9 | 5.5 | 18.9 | +23.2% |
| EDGM | Edgemode, Inc. | 3/9 | — | — | — |
| OPCH | Option Care Health, Inc. | 5/9 | 2.97 | 16.5 | +13% |
| BTSG | BrightSpring Health Services, Inc. | 7/9 | 1.78 | 71 | +28.2% |
About Aveanna Healthcare Holdings, Inc.
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
FAQ
Is AVAH financially healthy?
Aveanna Healthcare Holdings, Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does AVAH pay a dividend?
No, Aveanna Healthcare Holdings, Inc. does not currently pay a dividend.
How profitable is AVAH?
In FY2026, Aveanna Healthcare Holdings, Inc. had a net margin of 9.2% and a return on equity of 115.7%.
What is AVAH's P/E ratio?
Aveanna Healthcare Holdings, Inc.'s trailing price-to-earnings (P/E) ratio is about 8.4×, based on its latest annual earnings.
What is the analyst price target for AVAH?
The average Wall-Street price target for Aveanna Healthcare Holdings, Inc. is $10.05, about 11.0% above the recent price, from 10 analysts.
Is AVAH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Aveanna Healthcare Holdings, Inc.: a Piotroski F-score of 6/9, an Altman Z″ in the distress zone, a P/E of about 8.4×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-01-03. Facts plus Stocktoria's own computed scores — not investment advice.